ConductScience.org, home

Trial · NCT02847624

Results by group37

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Estimated Slope of Total Kidney Volume During Pre-administration and AdministrationADPKDPre-administration6.7517Standard Deviation 0.2183%/year
Estimated Slope of Total Kidney Volume During Pre-administration and AdministrationADPKDDuring administration3.6811Standard Deviation 0.9514%/year
The Number of Cases in Which ALT Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKDBaseline1672participants
The Number of Cases in Which ALT Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD500 days1210participants
The Number of Cases in Which ALT Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD1000 days1007participants
The Number of Cases in Which ALT Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD1500 days706participants
The Number of Cases in Which ALT Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD2000 days402participants
The Number of Cases in Which ALT Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD2500 days47participants
The Number of Cases in Which ALT Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD3000 days0participants
The Number of Cases in Which AST Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKDBaseline1672participants
The Number of Cases in Which AST Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD500 days1232participants
The Number of Cases in Which AST Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD1000 days1027participants
The Number of Cases in Which AST Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD1500 days715participants
The Number of Cases in Which AST Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD2000 days413participants
The Number of Cases in Which AST Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD2500 days47participants
The Number of Cases in Which AST Never Exceeded Three Times the Upper Limit of Normal (30 IU/L)ADPKD3000 days0participants
Estimated Slope of Estimated Glomerular Filtration Rate (e-GFR) During Pre-administration and AdministrationADPKDPre-administration-3.6272Standard Error 0.3572%/year
Estimated Slope of Estimated Glomerular Filtration Rate (e-GFR) During Pre-administration and AdministrationADPKDDuring-treatment-3.2561Standard Error 0.0552%/year
The Number and Percentage of Adverse Events Observed in Patients Aged 65 Years and OlderADPKDElderly patients87Participants
The Number and Percentage of Adverse Events Observed in Patients Aged 65 Years and OlderADPKDNon-elderly patients690Participants

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02847624/results